What is the lethal dose of Allergex (chlorpheniramine maleate) tablets?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lethal Dose of Allergex (Chlorpheniramine Maleate) Tablets

There is no established lethal dose for chlorpheniramine maleate in humans, but severe toxicity and death have been reported at blood concentrations as low as 0.2 mg/L in combination with other drugs, and rhabdomyolysis has occurred after ingestion of 400 mg (100 tablets of 4 mg each). 1, 2

Clinical Context and Toxicity Data

The available evidence on chlorpheniramine maleate toxicity comes primarily from case reports rather than systematic dose-response studies:

Documented Fatal Case

A fatal intoxication case reported a blood chlorpheniramine concentration of 0.2 mg/L in combination with other over-the-counter medications (guaifenesin and diphenhydramine), resulting in death from combined drug effects 2. This represents the clearest documentation of lethal blood levels, though it occurred in a polypharmacy context.

Non-Fatal Severe Toxicity

A 14-year-old patient who ingested 400 mg of chlorpheniramine maleate (100 tablets × 4 mg) developed:

  • Severe rhabdomyolysis with myoglobin >1,200 ng/mL
  • Creatine kinase peaking at 11,219 U/L
  • Palpitations and tachycardia
  • The patient survived with supportive care 1

This case demonstrates that 400 mg can cause life-threatening complications but is not uniformly fatal with appropriate medical intervention.

Mechanism of Toxicity

Chlorpheniramine overdose produces toxicity through multiple mechanisms:

  • Anticholinergic effects: Central nervous system depression, hallucinations, confusion
  • Cardiac effects: Tachycardia, arrhythmias, potential QT prolongation (though less pronounced than with some other antihistamines) 3
  • Muscular toxicity: Rhabdomyolysis (rare but documented) 1
  • Organ dysfunction: Potential renal and hepatic complications

Critical Clinical Pitfalls

The FDA drug label for Allergex warns to seek immediate medical help in case of overdose and contact Poison Control (1-800-222-1222) 4. This is the most authoritative guidance available.

Key Points for Clinical Management:

  1. First-generation antihistamines like chlorpheniramine are particularly dangerous in overdose due to their anticholinergic properties and CNS effects 5

  2. Elderly patients are at higher risk - first-generation antihistamines are considered potentially inappropriate medications in geriatric populations due to increased risk of confusion, falls, and anticholinergic toxicity 5

  3. Combination with other sedatives or anticholinergic drugs dramatically increases risk - the fatal case involved multiple drugs, highlighting synergistic toxicity 2

  4. Therapeutic doses are far below toxic levels: Standard dosing is 4-12 mg/day orally 3, 6, making the 400 mg ingestion represent a 33-100 fold overdose

Management Approach

In suspected chlorpheniramine overdose:

  • Immediate gastrointestinal decontamination if presenting within appropriate timeframe
  • Aggressive hydration and diuresis to prevent rhabdomyolysis complications 1
  • Cardiac monitoring for arrhythmias and QT changes
  • Electrolyte monitoring and correction
  • Supportive care for CNS depression and anticholinergic syndrome
  • Contact Poison Control immediately 4

The absence of a clearly defined LD50 in humans means any intentional overdose should be treated as potentially life-threatening, with aggressive supportive care and monitoring for at least 24 hours given the long elimination half-life (approximately 20 hours) 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.